(Q36674320)

15 August 2017

1 reference

title

Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress (English)

1 reference

15 August 2017

1 reference

León Ferder

1

1 reference

PubMed ID

17147916

15 August 2017

Felipe Inserra

series ordinal

2

1 reference

PubMed ID

17147916

15 August 2017

Manuel Martínez-Maldonado

series ordinal

3

1 reference

15 August 2017

1 June 2006

1 reference

Current Hypertension Reports

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

3

1 reference

15 August 2017

191-198

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-006-0050-7

15 August 2017

0 references

cites work

Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0050-7

NAD(P)H oxidase: role in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0050-7

Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0050-7

State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0050-7

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0050-7

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-006-0050-7

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

12 December 2020

The metabolic syndrome

1 reference

12 December 2020

Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis

1 reference

12 December 2020

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

1 reference

12 December 2020

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

12 December 2020

Minireview: Adiposity, Inflammation, and Atherogenesis

1 reference

12 December 2020

Enalapril and captopril enhance antioxidant defenses in mouse tissues

1 reference

12 December 2020

Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats

1 reference

12 December 2020

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

1 reference

12 December 2020

Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.

1 reference

12 December 2020

Hypoadiponectinemia is closely linked to endothelial dysfunction in man.

1 reference

12 December 2020

Cardiac transcriptional response to acute and chronic angiotensin II treatments

1 reference

12 December 2020

Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.

1 reference

12 December 2020

C-reactive protein and the risk of developing hypertension

1 reference

12 December 2020

Age-associated increase in oxidative stress and nuclear factor kappaB activation are attenuated in rat liver by regular exercise

1 reference

12 December 2020

Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure

1 reference

12 December 2020

Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.

1 reference

12 December 2020

Role of angiotensin-converting enzyme inhibition in glucose metabolism and renal injury in diabetes.

1 reference

12 December 2020

Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

CD4+ T cells in atherosclerosis

1 reference

12 December 2020

Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts

1 reference

12 December 2020

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

1 reference

12 December 2020

Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats

1 reference

12 December 2020

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

1 reference

12 December 2020

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

12 December 2020

Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-alpha in endothelial cells

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Enalapril attenuates oxidative stress in diabetic rats

1 reference

12 December 2020

The association between plasma adiponectin and insulin sensitivity in humans depends on obesity

1 reference

12 December 2020

Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells

1 reference

12 December 2020

Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-alpha -induced NF-kappa B activation and intercellular adhesion molecule-1 expression in endothelial cells

1 reference

12 December 2020

Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide

1 reference

12 December 2020

Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats

1 reference

12 December 2020

The tissue renin-angiotensin system in human pancreas

1 reference

12 December 2020

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

1 reference

12 December 2020

Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease

1 reference

12 December 2020

Ramipril and the development of diabetes.

1 reference

12 December 2020

Angiotensin in atherosclerosis

1 reference

12 December 2020

Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy

1 reference

12 December 2020

Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension

1 reference

12 December 2020

The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species

1 reference

12 December 2020

Increased oxidative stress in obesity and its impact on metabolic syndrome

1 reference

12 December 2020

Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role

1 reference

12 December 2020

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

1 reference

12 December 2020

The pathophysiology of aldosterone in the cardiovascular system

1 reference

12 December 2020

Insulin signaling pathways in time and space.

1 reference

12 December 2020

Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues

1 reference

12 December 2020

Enalapril and losartan attenuate mitochondrial dysfunction in aged rats

1 reference

12 December 2020

Angiotensin II: a double-edged sword in inflammation.

1 reference

12 December 2020

Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study

1 reference

12 December 2020

Inflammatory markers of coronary risk

1 reference

12 December 2020

Pancreatic beta-cells express phagocyte-like NAD(P)H oxidase

1 reference

12 December 2020

Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors

1 reference

12 December 2020

Association of hypoadiponectinemia with coronary artery disease in men

1 reference

12 December 2020

Preadipocyte conversion to macrophage. Evidence of plasticity.

1 reference

12 December 2020

Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension

1 reference

12 December 2020

Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver

1 reference

12 December 2020

Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension.

1 reference

12 December 2020

10.1007/S11906-006-0050-7

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17147916